---
title: "Eteplirsen - Duchenne Muscular Dystrophy"
sidebar: mydoc_sidebar
permalink: db06014-mesh-d020388-1.html
toc: false 
---


Path ID: `DB06014_MESH_D020388_1`
{% include image.html url="images/db06014-mesh-d020388-1.png" file="db06014-mesh-d020388-1.png" alt="db06014-mesh-d020388-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C000611335 | Eteplirsen | Drug |
| GO:0010467 | Gene expression | BiologicalProcess |
| UniProt:P11532 | Dystrophin | Protein |
| MESH:D020388 | Duchenne muscular dystrophy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Eteplirsen | POSITIVELY REGULATES | Gene Expression |
| Gene Expression | POSITIVELY REGULATES | Dystrophin |
| Dystrophin | DISRUPTED BY | Duchenne Muscular Dystrophy |
|---------|-----------|---------|

Comment: Eteplirsen is indicated for treatment of certain individuals with Duchenne muscular dystrophy. Its use is limited to those with a confirmed mutation of the DMD gene which would benefit from exon 51 skipping.

Reference: 
  - [https://go.drugbank.com/drugs/DB06014](https://go.drugbank.com/drugs/DB06014)
